SWI Portfolio Value Rises Another 25% 
To 339% of Initial Value
Los Angeles, Calif., September 21, 2017. We have not published a performance report for our SWI Portfolio for a while; we have been very busy exploring new opportunities. We have been working very closely with several new and promising companies conducting due diligence over the past few weeks. We will provide you with insights into those stocks over the next few weeks and will also publish a performance report on our SWI QuickPicks next week.

We would like to express our appreciation to our social media followers on Facebook, Twitter and LinkedIn, which have grown rapidly and consistently over the recent year. We will continue to provide you with critical news and valuable insights for all the companies that we cover via this network and also via our SWI website, to support your investment decisions.

Nevertheless, that does not mean that we have not continued to cultivate our SWI Portfolio and/or monitored it closely. We will inform you immediately about any unusual developments in any of the stocks in our portfolio. The good news is that we have increased the value by another 25% during the period to a total increase of 339% since inception. If you have followed us, you know that we have acquired positions for every stock in the SWI Portfolio and published this performance report since we opened the Portfolio, to make our performance stats completely transparent to our readers.

Since inception nearly three years ago, our SWI Portfolio has consistently outperformed the major indices and most "Big-Firm" research portfolios; and the gap is widening. Our research team is always scouting the markets for new and exceptional opportunities to add to the portfolio.

We also encourage you to follow the companies that we are covering on our StockWatchIndex (SWI) website, in our "QuickPicks" reports and with our SWI Research Reports on SWI Research.com. The SWI website is updated at least once daily with the latest news on the companies we cover and important news highlighting market trends, mainly in BioTech, Technology and other disruptive developments and what we believe to be solid investment opportunities.

We will never publish sensational headlines about any of the stocks that we have acquired, companies that we represent, or have issued research reports on. We simply do the research, report the facts and let our performance track record speak for itself. Considering our solid 2-year track record, it should be worthwhile following our coverage and spreading the word. There is power in numbers. If you like our reports and our reporting transparency, we would appreciate if you recommended us to your friends.
If you want to follow all other companies that we cover with more in depth research reports, go to our research site at www.swiresearch.com/report-index to download the reports,
or visit www.stockwatchindex.com for up to date news on the covered companies.
Please feel free to re-distribute the reports to your friends and colleagues.
Rainer Poertner - Chief Analyst
StockWatchIndex and SWI Research (SWI) are not registered investment advisers and the information provided herein or any other SWI publication is not to be construed as personal financial advice, or a solicitation to buy or sell stock. SWI makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in its publications or on its web sites. Some of the published information has been provided by the companies covered, generated by publicly available sources, or what SWI deems to be reliable third party sources, but SWI does not guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or warrants any results from use of the information. Readers are encouraged to consult their personal financial adviser before making any decisions to buy, sell or hold any securities mentioned herein, or any other of our publications. StockWatchIndex is not responsible for any error, mistake or shortcoming that may be occasioned at the time of publishing of the information in this publication, any other SWI publication, or its web sites and is not obligated to update and/or correct information. No liability is accepted by StockWatchIndex whatsoever for any direct, indirect or consequential loss arising from the use of the information. SWI expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information provided. SWI has not been compensated for this report, has acquired positions of every stock in this report for its portfolio and reserves the right to buy or sell positions at its sole discretion. The included information is subject to change without notice. Please visit  www.swiresearch.com/#!legal-ease/lmvw1   for a full text of our Disclaimer, Privacy policy and Terms of Use.